Purpose: Extramammary breast tumors are quite unusual but they might represent the first semiotic sign of non negative mammography. Thus, the need for an early and accurate diagnosis is crucial, with the purpose of planning and optimize the therapeuthical strategy and consequently to improve the clinical outcome of patients.
Methods: Due to the intrinsic characteristics of this technique, CESM lends itself as a useful and reliable tool for a complex diagnosis, since it may simultaneously provide both the data of the mammographic semiotic and the dynamic one of an examination with a contrast medium.
Results: In this article, the most common radiological signs of this type of lesions are summarized through an analysis of the published literature. The article focuses on the different mammographic semeiotics in primary and secondary malignant lesions in the breast, on the different aspects of metastases deriving from blood and lymphatic spread, as well as on the common analogies between metastatic lesions and fibroadenomas. Moreover, the characteristics of a unique case of breast metastasis from pleural mesothelioma, analyzed by Contrast-Enhanced Spectral Mammography, are described.
Conclusions: On the basis of our experience, CESM could represent an extremely valid method to address a correct diagnosis in complex cases of potentially metastatic lesions.
Download full-text PDF |
Source |
---|
Quant Imaging Med Surg
December 2024
Department of Radiotherapy, Peking Union Medical College Hospital, Beijing, China.
Background: In the traditional computed tomography (CT) simulation process, patients need to undergo CT scans before and after injection of iodine-based contrast agent, resulting in a cumbersome workflow and additional imaging dose. Contrast-enhanced spectral CT can synthesize true contrast-enhanced (TCE) images and virtual noncontrast (VNC) images in a single scan without geometric misalignment. To improve work efficiency and reduce patients' imaging dose, we studied the feasibility of using VNC images for radiotherapy treatment planning, with true noncontrast (TNC) images as references and explored its dosimetric advantages compared to using TCE images.
View Article and Find Full Text PDFQuant Imaging Med Surg
December 2024
Department of Nuclear Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Background: Under the Breast Imaging Reporting and Data System (BI-RADS), category 4 lesions have a high probability of malignancy. This study sought to investigate the efficacy of a model that combined the BI-RADS score with the enhancement score and clinical indicators in the diagnosis of BI-RADS 4 lesions based on contrast-enhanced spectral mammography (CESM) in breast cancer patients.
Methods: The data of female patients with BI-RADS scores of 4 who underwent CESM at the Department of Medical Imaging of the Third Affiliated Hospital of Soochow University from January 2018 to July 2023 were retrospectively collected.
Quant Imaging Med Surg
December 2024
Department of Radiology, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, China.
Background: The Ki-67 expression level, which represents the proliferation status of cells, serves as a prognostic marker for hepatocellular carcinoma (HCC); however, the immunochemistry method currently used to evaluate Ki-67 is invasive and is not suitable for patients who have lost the chance for surgery, such as those with advanced tumors or those with other serious organic diseases. This study aimed to investigate the value of quantitative dual-energy computed tomography (DECT) parameters in predicting the expression level of Ki-67 in HCC.
Methods: This study analyzed the data of 123 consecutive patients with HCC who underwent both Ki-67 immunohistochemistry analysis and two-phase contrast-enhanced DECT imaging.
J Clin Med
December 2024
Oncologic Breast Surgery Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy.
In alloplastic breast reconstruction, the choice of implant positioning and the selection of periprosthetic devices is a critical and challenging decision. Surgeons must navigate between various biologic and synthetic meshes, including acellular dermal matrices (ADM). This study aimed to propose a simple selection tool for periprosthetic devices in prepectoral breast reconstruction.
View Article and Find Full Text PDFBr J Radiol
December 2024
Department of Radiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province 510515, China.
Objectives: To investigate the capability of morphological and enhancement pattern analysis in contrast-enhanced mammography (CEM) to differentiate between benign and malignant papillary breast lesions.
Methods: This study involved 63 patients diagnosed with papillary breast lesions between January 2018 and December 2022. CEM was performed at two time intervals: between 2-3 min (T1, early phase) and 4-5 min (T2, later phase) after the injection of the contrast agent.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!